The prevention of prostate cancer--the dilemma continues.
Scardino
Peter T
PT
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects / Q000627:therapeutic use*; D018120:Finasteride / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000139:chemically induced / Q000473:pathology / Q000517:prevention & control*; D018570:Risk Assessment
D058891:5-alpha Reductase Inhibitors; D018931:Antineoplastic Agents, Hormonal; D018120:Finasteride